HK Stock Market Move | Jiangsu Lopal Tech. (02465) rose more than 3%. Investors INA and Aisis have agreed to subscribe for shares of the target company, with a total subscription amount of 200 million US dollars.
Longpan Technology (02465) rose more than 3%, as of the time of publication, it was up 3.64% at HK$4.84, with a turnover of HK$9.9293 million.
Jiangsu Lopal Tech. (02465) rose by more than 3%, closing at a 3.64% increase, at 4.84 Hong Kong dollars, with a turnover of 9.9293 million Hong Kong dollars.
On the news front, on January 8th, Jiangsu Lopal Tech. announced that it had signed a subscription agreement with investors INA and Aisis, who agreed to subscribe for shares of the target company, accounting for approximately 34.01% and 11.34% respectively after the company's share expansion. The total subscription price is 200 million US dollars, which the investors will pay to the target company on the completion date. After the completion, Jiangsu Lopal Tech. will hold approximately 64.03% of the existing shareholders' equity, while the existing shareholders will hold 54.65% of the target company's equity.
In addition, the announcement mentioned that the company will adjust its external investment plans, mainly to strengthen research and market expansion in the field of lithium iron phosphate positive electrode materials. According to financial data, the total assets of the target company as of October 31, 2024, were 8.14 billion yuan, liabilities were 3.01 billion yuan, and revenue had not officially started. The company plans to hold an extraordinary shareholders' meeting on January 24, 2025, for shareholders to consider and approve the above-mentioned transactions and external investment adjustments.
Related Articles

withdraw liquidation application
.png)
Subsidiary of GIANT BIOGENE (02367) received the "Medical Device Registration Certificate of the People's Republic of China" for the recombined Type I 1 subtype collagen freeze-dried fiber product.

WASION HOLDINGS (03393): Willfar Information Technology's net profit attributable to shareholders for the first three quarters increased by 12.24% year-on-year to 474 million yuan.
withdraw liquidation application

Subsidiary of GIANT BIOGENE (02367) received the "Medical Device Registration Certificate of the People's Republic of China" for the recombined Type I 1 subtype collagen freeze-dried fiber product.
.png)
WASION HOLDINGS (03393): Willfar Information Technology's net profit attributable to shareholders for the first three quarters increased by 12.24% year-on-year to 474 million yuan.

RECOMMEND

Why European Automakers Are Opposing Dutch Sanctions
20/10/2025

Domestic Commercial Rockets Enter Batch Launch Era: Behind the Scenes a Sixfold Cost Gap and Reusability as the Key Breakthrough
20/10/2025

Multiple Positive Catalysts Lift Tech Stocks; UBS Elevates China Tech to Most Attractive, Citing AI as Core Rationale
20/10/2025